James N. Wilson, Director at CORCEPT THERAPEUTICS INC (CORT), sold 10,000 shares at $82.69 ($832K) on 2026-06-16, disclosed to the SEC on 2026-06-18.
Scheduled sale ($832k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.69 | 4,177 | $345K | 41.5% |
| 2 | $83.57 | 5,823 | $487K | 58.5% |
| Total | $83.20 avg | 10,000 | $832K | 100% |
| Filing → |
| CORT | SELL | 2026-07-17 | $883K | — | Filing → |
| CORT | SELL | 2016-11-14 | $1.4M | — | Filing → |
| CORT | SELL | 2016-01-06 | $6K | — | Filing → |